SNWV vs. LQDA, ESTA, PLSE, BLFS, TNDM, MDXG, INMD, KMTS, IRMD, and SIBN
Should you be buying Sanuwave Health stock or one of its competitors? The main competitors of Sanuwave Health include Liquidia Technologies (LQDA), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Tandem Diabetes Care (TNDM), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), iRadimed (IRMD), and SiBone (SIBN). These companies are all part of the "medical equipment" industry.
Sanuwave Health vs. Its Competitors
Sanuwave Health (NASDAQ:SNWV) and Liquidia Technologies (NASDAQ:LQDA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.
Liquidia Technologies has a consensus price target of $26.89, indicating a potential upside of 43.25%. Given Liquidia Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Liquidia Technologies is more favorable than Sanuwave Health.
Sanuwave Health has a net margin of -89.86% compared to Liquidia Technologies' net margin of -903.80%. Sanuwave Health's return on equity of 0.00% beat Liquidia Technologies' return on equity.
In the previous week, Liquidia Technologies had 5 more articles in the media than Sanuwave Health. MarketBeat recorded 7 mentions for Liquidia Technologies and 2 mentions for Sanuwave Health. Liquidia Technologies' average media sentiment score of 0.47 beat Sanuwave Health's score of 0.00 indicating that Liquidia Technologies is being referred to more favorably in the news media.
42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 64.5% of Liquidia Technologies shares are owned by institutional investors. 14.9% of Sanuwave Health shares are owned by insiders. Comparatively, 26.5% of Liquidia Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Sanuwave Health has higher revenue and earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.
Sanuwave Health has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500.
Summary
Liquidia Technologies beats Sanuwave Health on 11 of the 16 factors compared between the two stocks.
Get Sanuwave Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNWV and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sanuwave Health Competitors List
Related Companies and Tools
This page (NASDAQ:SNWV) was last updated on 7/24/2025 by MarketBeat.com Staff
